<DOC>
	<DOCNO>NCT02860624</DOCNO>
	<brief_summary>This study design evaluate efficacy tolerability ilaprazole relative esomeprazole heal erosive esophagitis resolve accompany symptom GERD .</brief_summary>
	<brief_title>Ilaprazole Treatment Gastroesophageal Reflux Disease ( GERD ) Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Consenting patient eligible enrollment : 1870 year age , least one two symptom , heartburn reflux , photographically document erosive esophagitis confirm esophagogastroduodenoscopy ( EGD ) , grade accord Los Angeles ( LA ) Classification ( AD ) , within 5 day randomization treatment . Female patient require nonpregnant , nonlactating , postmenopausal , surgically sterilize , use medically acceptable form birth control , determine investigator . Women child bear potential receive pregnancy test . Patients ineligible : cancerous peptic ulcer , ZollingerEllison syndrome , varix esophagus fundus stomach know history gastric acid suppression operation , esophageal operation peptic operation simple closure perforation , severe complication , severe disease digestive tract Crohn 's disease ulcerative colitis , severe systemic disease , take proton pump inhibitor within 5 day three consecutive day within two week immediately precede start study drug , participate clinical trial investigational drug device within past three month , hypersensitivity idiosyncratic reaction ilaprazole , esomeprazole benzimidazole , alcoholic intemperance , drug addiction improper habit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>GERD</keyword>
</DOC>